Filtered By:
Source: Heart, Lung and Circulation
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 240 results found since Jan 2013.
Embedding Best Evidence Cultural and Clinical Stroke Care in Training
Cultural change within hospitals is difficult, and discussions around provision of care to meet the needs of Aboriginal patients can be fraught with challenges, despite evidence of disparities in hospital care and poorer health and social post-hospital outcomes. The Department for Health and Wellbeing sought to develop an evidence-based education package for health care staff to support improvements in the provision of in-hospital stroke care for and with Aboriginal stroke patients and family.
Source: Heart, Lung and Circulation - May 24, 2019 Category: Cardiology Authors: Katharine McBride, Susan Hillier, Tim Kleinig, Karen Dixon, Talisha King, Anna Dowling, Janet Kelly Tags: P23 Source Type: research
Meeting Social and Cultural Needs During an Emergency
Social and cultural barriers to care impact the journey to acute treatments for Aboriginal patients with chest pain and suspected acute coronary syndrome or neurological symptoms and suspected stroke. There is a recognised need to improve the quality of, and accessibility to, transfer and retrieval practices for these patients. Such actions improve the whole patient journey. The aim was to integrate supports to meet the cultural and social needs of Aboriginal patients into clinical pathways and procedures of emergency services.
Source: Heart, Lung and Circulation - May 24, 2019 Category: Cardiology Authors: Katharine McBride, Herbert Mack, Gloria Mejia, Philip Tideman, Nola Whyman, Major Sumner, Janice Rigney, Kim Morey Tags: P22 Source Type: research
Stroke Risk Factors and Outcomes in Indigenous Verse Non-Indigenous Australians
Background: Stroke risk factors are well known, but there is little data on the prevalence of stroke risk factors in Indigenous Australian cohorts. We aim to assess the risk factors and the outcomes after stroke and compare these in Indigenous and non-Indigenous Australians presenting with acute strokes to the Wagga Wagga Rural Referral Hospital.
Source: Heart, Lung and Circulation - May 24, 2019 Category: Cardiology Authors: Angela Dos Santos, Katherine Mohr, Martin Jude, Neil Simon, Candice Delcourt Tags: P20 Source Type: research
Stroke Incidence and Outcomes in Indigenous Australians
We present the first prospective population-based pilot study of stroke incidence and outcomes in Indigenous Australians.
Source: Heart, Lung and Circulation - May 24, 2019 Category: Cardiology Authors: Angela Dos Santos, Anna Balabanski, Tim Kleinig, Amanda Thrift, Alex Brown, Judith Katzenellenbogen, Edmung Cheong Tags: P19 Source Type: research
Incidence and Predictors of Sudden Cardiac Death After a Major Non-Fatal Cardiovascular Event
Sudden cardiac death (SCD) still accounts for the majority of deaths from the four major cardiovascular events (myocardial infarction (MI), heart failure (HF), atrial fibrillation (AF), and stroke) despite substantial progress on prevention.
Source: Heart, Lung and Circulation - April 17, 2019 Category: Cardiology Authors: Jia-Li Feng Tags: Original Article Source Type: research
Cardiac Rehabilitation: Are People With Stroke or Transient Ischaemic Attack Being Included? A Cross-Sectional Survey
Cardiac rehabilitation (CR) may be an effective secondary prevention program for people with stroke or transient ischaemic attack (TIA). The aims of this study were to determine whether people with stroke or TIA were attending CR in Australia and if there were any barriers to attendance.
Source: Heart, Lung and Circulation - April 10, 2019 Category: Cardiology Authors: Tom Howes, Niru Mahenderan, Nicole Freene Tags: Original Article Source Type: research
Stroke Risk Stratification: CHA2DS2-VA or CHA2DS2-VASc?
It is with interest that we note the letter by Drs Overvad and colleagues in which concern is expressed regarding a newly proposed strategy in the recently published Australian Guidelines for Atrial Fibrillation (AF) [1]. Specifically we recommend that female sex category be dropped from the CHA2DS2-VASc score; therefore recommending a CHA2DS2-VA score.
Source: Heart, Lung and Circulation - March 30, 2019 Category: Cardiology Authors: David Brieger, Cia Connell, Ben Freedman Tags: Letter to the Editor Source Type: research
Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation
Non-vitamin K antagonist oral anticoagulants (NOACs) have been recommended as preferred options for stroke prevention in patients with atrial fibrillation (AF) versus warfarin by guidelines worldwide.
Source: Heart, Lung and Circulation - March 19, 2019 Category: Cardiology Authors: Piyameth Dilokthornsakul, Surakit Nathisuwan, Rungroj Krittayaphong, Aurauma Chutinet, Unchalee Permsuwan Tags: Original Article Source Type: research
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke
Prolonged screening for the presence of atrial fibrillation (AF) is recommended after cryptogenic stroke (CS) and different electrocardiographic markers of atrial cardiopathy have been proposed as tools to identify patients at high-risk for AF.
Source: Heart, Lung and Circulation - November 12, 2018 Category: Cardiology Authors: Maurizio Acampa, Pietro Enea Lazzerini, Francesca Guideri, Rossana Tassi, Ilenia Andreini, Carlo Domenichelli, Alessandra Cartocci, Giuseppe Martini Tags: Original Article Source Type: research
Pioneering Australia ’s First Atrial Fibrillation Guidelines
Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice, and has a major impact on morbidity and mortality; linked to one in 12 deaths in Australia [2]. Though appropriate rhythm management and stroke prevention are essential, arguably, prevention is likely to achieve the greatest impact on these outcomes. These Australian-first guidelines [1], developed by the Heart Foundation and the Cardiac Society of Australia and New Zealand, incorporate the latest contemporary evidence in AF prevention by recommending a holistic approach.
Source: Heart, Lung and Circulation - November 1, 2018 Category: Cardiology Authors: Cia Connell, Garry L.R. Jennings Tags: Editorial Source Type: research
Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device
Left atrial appendage occlusion (LAAO) is increasingly used for stroke prevention in patients with atrial fibrillation who are considered unsuitable for a lifelong oral anticoagulant regimen. Recently, a single-centre study reported device-related thrombus formation in 16.7% of patients treated with the second-generation Amulet device (St. Jude Medical, St. Paul, MN, USA), presenting a potential major safety concern. As “real-world” data on device-related thrombus formation following LAAO with the Amulet occluder are scarce, we aimed to evaluate this outcome in a retrospective registry.
Source: Heart, Lung and Circulation - September 21, 2018 Category: Cardiology Authors: Micha ël Peyrol, Jennifer Cautela, Erwan Salaun, Charlène Miola, Frederic Franceschi, Franck Thuny, Johan Pinto, Marc Laine, Alexandre Maximovitch, Franck Paganelli, Sébastien Armero, Laurent Bonello Tags: Original Article Source Type: research
Stroke Risk Stratification: CHA2DS2-VA or CHA2DS2-VASc?
Source: Heart, Lung and Circulation - September 4, 2018 Category: Cardiology Authors: Thure Filskov Overvad, Tatjana S. Potpara, Peter Br ønnum Nielsen Tags: Letter to the Editor Source Type: research
Ischaemic Stroke and the Echocardiographic “Bubble Study”: Are We Screening the Right Patients?
Patent foramen ovale (PFO) is a potential mechanism for paradoxical embolism in cryptogenic ischaemic stroke or transient ischaemic attack (TIA). PFO is typically demonstrated with agitated saline ( “bubble study”, BS) during echocardiography.We hypothesised that the BS is frequently requested in patients that have a readily identifiable cause of stroke, that any PFO detected is likely incidental, and its detection often does not alter management.
Source: Heart, Lung and Circulation - August 1, 2018 Category: Cardiology Authors: Paul Maggiore, Jamie Bellinge, David Chieng, David White, Nick S.R. Lan, Biyanka Jaltotage, Umar Ali, Madeleine Gordon, Kevin Chung, Paul Stobie, Justin Ng, Graeme J. Hankey, Brendan McQuillan Tags: Original Article Source Type: research
Circulating Galectin-3 is Associated With Left Atrial Appendage Remodelling and Thrombus Formation in Patients With Atrial Fibrillation
Left atrial appendage (LAA) is gaining increasing attention in patients with atrial fibrillation (AF) in the context of cardioembolic stroke. Galectin-3 (Gal-3) is a mediator of profibrotic pathways and is associated with an increased incidence of heart failure. However, the role of Gal-3 in LAA remodelling and thrombus formation in AF has not been evaluated.
Source: Heart, Lung and Circulation - May 12, 2018 Category: Cardiology Authors: Zhengde Tang, Lefeng Zeng, Yanjun Lin, Zhihua Han, Jun Gu, Changqian Wang, Huili Zhang Tags: Original Article Source Type: research
Inflammation and Atrial Electrical Remodeling in Patients With Embolic Strokes of Undetermined Source
About one third of ischaemic strokes are classified as embolic strokes of undetermined source (ESUS). A silent atrial fibrillation (AF) may play a pathogenic role in these strokes and P wave dispersion (PWD), representing an electrocardiograph (ECG) predictor for paroxysmal AF, thereby a potential marker of covert cardioembolism, was found to be increased in cryptogenic stroke. Furthermore, current evidence links AF to inflammation: inflammatory markers, such as high-sensitive C-reactive protein (hsCRP), have been related to the development and persistence of AF, possibly by promoting atrial remodelling.
Source: Heart, Lung and Circulation - May 8, 2018 Category: Cardiology Authors: Maurizio Acampa, Pietro Enea Lazzerini, Francesca Guideri, Rossana Tassi, Andrea Lo Monaco, Giuseppe Martini Tags: Original Article Source Type: research
